News, 19 June 2002
Dutch government figures which appear to indicate that the number of
euthanasia cases fell for the second consecutive year in 2001 have been
treated with scepticism. There were 2,054 official reports of
euthanasia in the Netherlands last year, down from 2,216 in 1999. The
law which officially legalised euthanasia in the Netherlands only came
into effect on the 1 April this year, before which euthanasia was
tolerated as long as reporting and other requirements were met. A
spokesman for the Dutch health ministry suggested that the decline may
have been due to increasing knowledge of palliative care, but Cry for
Life, a Dutch pro-life organisation, said that the willingness of
doctors to report euthanasia was decreasing. One report has suggested
that cases of euthanasia may be going unrecorded because doctors
consider the administration of pain relief with the intention of ending
life to be "normal medical treatment". [
CNSNews, 14 June]
A prominent Swiss advisory panel has supported government proposals to
authorise destructive stem cell research on human embryos. It is
thought that the vote by members of the National Advisory Commission on
Biomedical Ethics makes it more likely that the government proposals
will be approved by parliament later this year. The panel recommended
that strict rules should apply to the research, including the condition
that embryos must be killed after five days' development. [
Reuters, 19 June]
The United Nations Population Division's updated
review
of global abortion practice claims that there are 50 million induced
abortions in the world each year [although this figure is not backed by
good statistics and may be considerably exaggerated]. The review also
observes that 98% of the countries of the world permit abortion to save
the life of the mother, 63% to preserve the mother's physical health,
62% to preserve mental health, 43% in cases of rape and incest, 33% on
social and economic grounds, and 27% on demand. [
LifeSite, 18 June]
An Israeli doctor is developing a treatment for heart disease which
involves the transfer of a patient's own bone marrow stem cells
directly into the heart. Dr Ran Kornowski developed the technique
during a sabbatical in New York and has now used it to treat a patient
at the Rabin Medical Centre in Petah Tikva, central Israel. Dr
Kornowski and his team extracted about 30 million stem cells from the
patient, which they hope will trigger the production of new blood
vessels in the patient's damaged heart muscle. [
The Jerusalem Post, 17 June]
Adult stem cell technology constitutes an ethical and more promising
alternative to the use of stem cells extracted from embryos and
so-called therapeutic cloning.
To subscribe to SPUC's email information services, please visit www.spuc.org.uk/em-signup. The reliability of the news herein is dependent on that of the cited sources, which are paraphrased rather than quoted. Opinions expressed are not necessarily those of the society. © Society for the Protection of Unborn Children, 2012